Liver function improvement after human placental extract injections in patients with chronic liver disease: Thirty case reports

Figure 1 Alanine transferase and aspartate aminotransferase changes in patients with chronic liver disease who were administered human placental extract once per week and twice per week. A: Alanine transferase level; B: Aspartate aminotransferase level; C: Alanine transferase level; D: Aspartate aminotransferase level. Data were analyzed using the paired samples t-test. ^aP < 0.05. ^bP < 0.01. ALT: Alanine transferase; AST: Aspartate aminotransferase.

Figure 2 Chronic liver disease normalization rates and alanine transferase based on the frequency of human placental extract administration observed using abdominal ultrasonography. A: Chronic liver disease normalization rates; B: Alanine transferase normalization rates. ALT: Alanine transferase.